Epredia Email Format
Biotechnology ResearchNew Hampshire, United States501-1000 Employees
Epredia is a global biotechnology company that focuses on precision cancer diagnostics and develops technologies to support the anatomical pathology field. The company is headquartered in Portsmouth, New Hampshire (20 Post Road) and employs between 501 and 1,000 people. Epredia was established in July 2019 through the acquisition by PHC Group of Thermo Fisher Scientific assets, with historical roots dating back to 1937. Its portfolio includes brands such as Shandon, Microm, Menzel Gläser, and Richard-Allan Scientific, and it offers digital pathology solutions such as the E1000 Dx system. Epredia is a subsidiary of PHC Holdings Corporation and has received recognition in the industry, including the 2026 MedTech Breakthrough Award for Best New Diagnostic Technology Solution.